Delivery Order SPE2DB24D2011-SPE2DB25FBRUD
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- This delivery order, awarded on September 8, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,652.76. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (unit dose, 100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with a ceiling value of $1,128.56 and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lyrica 100 mg capsules in quantities of 90 units, with a ceiling value of $6,189.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lyrica 100 mg capsules in a 90-count quantity with a ceiling value of $1,183.60. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,958.95 delivery order from the Defense Logistics Agency (DLA) for 90 capsules of Lyrica 100 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract award utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $9,964.18 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.10 to AmerisourceBergen Drug Corp for the supply of Lyrica (pregabalin) 50 mg capsules in a 90-count quantity. This competitive award, issued on July 23, 2025, with a completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRUDDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As one of the federal government's major pharmaceutical distributors, AmerisourceBergen supplies a broad range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Lyrica (pregabalin) is a neurological treatment commonly used within military and federal healthcare settings, and this order fulfills ongoing pharmaceutical needs within the broader DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/9/25 |